Medicare Enrolled
Dr. James Leake
Radiation Oncology · Austin, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Leake from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leake?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Leake
Dr. James Leake is a radiation oncology specialist in Austin, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Leake performed 11,061 Medicare services across 2,240 unique beneficiaries.
Between the years covered by Open Payments, Dr. Leake received a total of $91 from 2 pharmaceutical and/or device companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Leake is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 7% volume in TX
$91 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,061
Medicare services
Top 7% in TX for radiation oncology
2,240
Unique beneficiaries
$134
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,006 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,850 | $0 | $1 |
| Lutetium Lu 177 vipivotide tetraxetan therapeutic injection A therapeutic injection of Lutetium Lu 177 vipivotide tetraxetan administered in units of millicuries. |
3,200 | $194 | $497 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
531 | $602 | $2,212 |
| Gallium Ga-68 dotatate diagnostic injection A diagnostic injection of Gallium Ga-68 dotatate used for imaging. The dose specified is 0.1 millicurie. |
390 | $115 | $397 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
371 | $7 | $129 |
| Gallium Ga-68 gozetotide diagnostic injection A diagnostic injection of the radiopharmaceutical Gallium Ga-68 gozetotide (brand name Illuccix) used for imaging purposes. |
370 | $770 | $2,744 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
145 | $129 | $681 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 139 | $90 | $374 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
136 | $56 | $287 |
| Piflufolastat F-18 diagnostic injection A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie. |
120 | $515 | $1,889 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
67 | $376 | $1,564 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
60 | $5 | $21 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
58 | $7 | $120 |
| CT scan of chest blood vessels with contrast A CT scan that uses contrast dye to create detailed images of the blood vessels in the chest. |
51 | $65 | $1,316 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
39 | $10 | $62 |
| Lung ventilation and perfusion scan A nuclear medicine test that uses radioactive tracers to evaluate both air flow (ventilation) and blood flow (perfusion) in the lungs. |
37 | $38 | $694 |
| Technetium Tc-99m medronate diagnostic injection An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study. |
37 | $36 | $138 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
34 | $58 | $260 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
31 | $81 | $522 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
31 | $16 | $418 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
29 | $6 | $121 |
| Whole body bone and joint nuclear medicine scan A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body. |
25 | $201 | $739 |
| Nuclear medicine liver and bile duct scan A nuclear medicine imaging test to evaluate the liver and bile duct system. |
23 | $27 | $526 |
| Radioactive drug therapy through a vein Administration of a radioactive medication directly into the bloodstream via an intravenous line. |
21 | $122 | $629 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
19 | $300 | $1,231 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
18 | $19 | $382 |
| I-123 ioflupane diagnostic injection A diagnostic injection of I-123 ioflupane used for imaging studies, with a dose up to 5 millicuries. |
18 | $1,952 | $6,814 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
17 | $7 | $133 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
17 | $8 | $212 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
17 | $83 | $269 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
16 | $6 | $105 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
16 | $36 | $215 |
| Ankle X-ray, minimum 3 views An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints. |
15 | $7 | $110 |
| Lymphatic system nuclear medicine study A nuclear medicine imaging test used to evaluate the structure and function of the lymphatic system. |
15 | $44 | $833 |
| Nuclear medicine liver and bile duct study with drugs A nuclear medicine imaging test to examine the liver and bile duct system using administered drugs. |
14 | $299 | $973 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 14 | $33 | $132 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
12 | $6 | $117 |
| Parathyroid nuclear medicine study with SPECT/CT A nuclear medicine imaging test that uses a radioactive tracer to visualize the parathyroid glands, combined with SPECT and CT scans for detailed anatomical localization. |
12 | $333 | $1,800 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
12 | $24 | $99 |
| Injection, sincalide, 5 micrograms | 12 | $90 | $464 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
11 | $165 | $873 |
| Bone scan with multiple time points A nuclear medicine imaging test that captures images of the bones at various intervals to assess bone health and detect abnormalities. |
11 | $274 | $876 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
92.1% medium
7.5% routine
Industry Payment Transparency
Open Payments through 2023 ↗$91
Total received (2023-2023)
Bottom 32% in TX for radiation oncology
2
Companies
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$91 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$91
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$60
Novartis Pharmaceuticals Corporation
$31
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
ILLUCCIX · PLUVICTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Radiation oncologists within 10 mi
144
Per 100K population
11.0
County median income
$97,169
Nearest hospital
DELL SETON MED CENTER AT THE UNIVERSITY OF TX
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Leake is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Leake experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Leake performed 4,850 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leake receive payments from pharmaceutical companies?
Yes. Dr. Leake received a total of $91 from 2 companies across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leake's costs compare to other radiation oncologists in Austin?
Dr. Leake's average Medicare payment per service is $134. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leake) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Radiation Oncologists in Austin
Browse radiation oncologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Radiation Oncologists in TX
Radiation oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Radiation Oncologists in TX
Which TX radiation oncologists receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology